Although, TREM2 mutations are rare, their observed effect size is comparable to the APOEε4 allele, which represents the strongest genetic risk factor for late onset AD (Ulrich et al., 2017; Yeh et al., 2017; Carmona et al., 2018). This evidence concerns the gene TREM2 and Alzheimer disease.